Patent · US Active

IBAT inhibitors for the treatment of liver diseases

US10487111B2 · kind B2 · utility

19Cited by

38References

10Claims

0Family size

Assignee

ALBIREO AB · SE

Inventors

Per-Göran Gillberg · Timrå, SE
Hans Graffner · Helsingborg, SE
Ingemar Starke · Gothenburg, SE

Key dates

Filing date	Feb 12, 2018
Grant date	Nov 26, 2019
Priority date	—
Expiry date	Feb 12, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2121/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention regards specific IBAT inhibitors useful in the prophylaxis and/or treatment of a liver disease. It also relates to compositions comprising these IBAT inhibitors, a method for treatment of the disorders and a kit comprising the substances or the compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.